Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.860
+0.040 (1.42%)
At close: Sep 15, 2026, 4:00 PM EDT
2.820
-0.040 (-1.40%)
After-hours: Sep 15, 2026, 5:07 PM EDT
Entera Bio Revenue
In the year 2025, Entera Bio had annual revenue of $42.00K, down -76.80%.
Revenue (ttm)
$42.00K
Revenue Growth
-76.80%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
22
Market Cap
495.19M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 42.00K | -139.00K | -76.80% |
| Dec 31, 2024 | 181.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 134.00K | -437.00K | -76.53% |
| Dec 31, 2021 | 571.00K | 206.00K | 56.44% |
| Dec 31, 2020 | 365.00K | 129.00K | 54.66% |
| Dec 31, 2019 | 236.00K | -264.00K | -52.80% |
| Dec 31, 2018 | 500.00K | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Puma Biotechnology | 231.24M |
| Autolus Therapeutics | 117.39M |
| ARS Pharmaceuticals | 116.93M |
| Prelude Therapeutics | 22.42M |
| Capricor Therapeutics | 11.13M |
| Opus Genetics | 9.86M |
| Artiva Biotherapeutics | 251.00K |
ENTX News
- 19 days ago - Correction: Entera to Participate in Upcoming Fall Investor Conferences - GlobeNewsWire
- 19 days ago - Entera to Participate in Upcoming Fall Investor Conferences - GlobeNewsWire
- 25 days ago - Entera Bio files to sell 134.8M ordinary shares for holders - TheFly
- 25 days ago - Entera Bio Registration statement: Registration filing - Filings
- 4 weeks ago - Entera Bio names Riccardo Paolo Camisasca as chief medical officer - TheFly
- 4 weeks ago - Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation - GlobeNewsWire
- 4 weeks ago - Entera Bio Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 5 weeks ago - Entera Announces Second Quarter 2026 Financial Results and Business Updates - GlobeNewsWire